At Antibody Design, we use state of the art antibody design technology to develop immuno-detection assays. Having identified a valuable opportunity in infectious disease, we are currently building a prototype for a novel point-of-care, rapid action tool that can aid the diagnosis and treatment of influenza virus. This test will be a universal influenza diagnostic platform which will allow accurate diagnosis of infection for the medical, veterinary and agricultural industry.
OUR TEST IS DIFFERENT
Current diagnostic tests for Influenza virus use antibodies that target nuclear proteins. Since they are inside of the virus they are difficult to detect and the average sensitivity is 50%.
Antibody Design instead targets conserved and universally present proteins on the surface of the virus, which are more abundant and more accessible, leading to a better detection.